Related Experiment Video
Updated: Aug 29, 2026

Why Quantification Matters: Characterization of Phenotypes at the Drosophila Larval Neuromuscular Junction
Published on: May 12, 2016
Functional characterisation of a mutant actin (Met132Val) from a patient with nemaline myopathy
Steven Marston1, Mahmooda Mirza, Hassan Abdulrazzak
1National Heart and Lung Institute, Imperial College, Dovehouse St, London SW3 6LY, UK. s.marston@imperial.ac.uk
Abstract:
The mutation Met132Val in the ACTA1 gene was identified in a patient with mild nemaline myopathy (NM). We examined actin mRNA and protein from biopsy samples. Sixty-one percent of the mRNA from the biopsy was not cleaved with BstX1, indicating the presence of mutant messenger in vivo. Monomeric actin was extracted from 2.5 mg of mutant muscle and wild type muscle. A proportion of the NM actin did not polymerise in 50 mM KCl, 2.5 mM MgCl2 but all the wild-type actin did. NM actin was fully polymerised by 50 mM KCl, 2.5 mM MgCl2, 150 nM rhodamine-phalloidin. Thin filaments reconstituted with this co-polymer were different from wild-type. The NM actin produces faster sliding of thin filaments at pCa5 and higher relative isometric force. We conclude that the mutant mRNA and protein is expressed and that the mutation reduces polymerisability and alters thin filament function.
Insights
A mutation in the ACTA1 gene causes mild nemaline myopathy (NM) by affecting actin protein polymerization and thin filament function. This study confirms mutant actin expression and its impact on muscle performance.
Area of Science:
- Molecular Biology
- Genetics
- Muscle Physiology
Background:
- Nemaline myopathy (NM) is a muscle disorder.
- The ACTA1 gene provides instructions for making actin, a protein crucial for muscle contraction.
- Specific mutations in ACTA1 can lead to NM.
Purpose of the Study:
- To investigate the functional consequences of the Met132Val mutation in the ACTA1 gene.
- To determine if the mutant ACTA1 mRNA and protein are expressed in vivo.
- To analyze the effect of the mutation on actin polymerization and thin filament function.
Main Methods:
- Analysis of actin mRNA from patient muscle biopsy using BstX1 cleavage.
- Extraction and purification of monomeric actin from both mutant and wild-type muscle.
- In vitro polymerization assays of actin under varying conditions (KCl, MgCl2, rhodamine-phalloidin).
- Reconstitution of thin filaments and assessment of sliding velocity and isometric force.
Main Results:
- Mutant ACTA1 mRNA was detected in vivo, with 61% resistant to BstX1 cleavage.
- A portion of the mutant actin exhibited reduced polymerisability compared to wild-type actin.
- Reconstituted thin filaments with mutant actin showed altered function, including faster sliding and higher relative isometric force.
- The mutation was confirmed to be expressed at both mRNA and protein levels.
Conclusions:
- The Met132Val mutation in ACTA1 is expressed in vivo and leads to abnormal actin.
- The mutation impairs actin polymerisability and alters the functional properties of muscle thin filaments.
- These molecular and functional changes contribute to the pathogenesis of mild nemaline myopathy.
Related Concept Videos
Actin Polymerization and Cell Motility
Actin cytoskeleton dynamics can produce pushing, pulling, and resistance forces that help the cell to migrate.
Introduction to Actin
Overview of Myosin Structure and Function
Alterations in Muscle Tone lll
The Sarcomere
Each myosin...

